|
ERCC8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.247700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.040570E-01 |
| Normal-vs-Stage2 |
2.633200E-01 |
| Normal-vs-Stage3 |
8.938400E-02 |
| Normal-vs-Stage4 |
1.564630E-01 |
| Stage1-vs-Stage2 |
9.117600E-01 |
| Stage1-vs-Stage3 |
3.750800E-01 |
| Stage1-vs-Stage4 |
7.513400E-01 |
| Stage2-vs-Stage3 |
5.830000E-01 |
| Stage2-vs-Stage4 |
8.145400E-01 |
| Stage3-vs-Stage4 |
8.138000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.335800E-02 |
| Normal-vs-AfricanAmerican |
3.815800E-01 |
| Normal-vs-Asian |
5.123600E-02 |
| Caucasian-vs-AfricanAmerican |
5.977800E-01 |
| Caucasian-vs-Asian |
4.820400E-01 |
| AfricanAmerican-vs-Asian |
3.954600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.977900E-02 |
| Normal-vs-Female |
6.332800E-01 |
| Male-vs-Female |
1.888850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.559600E-02 |
| Normal-vs-Extreme_Weight |
3.154200E-02 |
| Normal-vs-Obese |
3.247600E-01 |
| Normal-vs-Extreme_Obese |
3.617600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.281000E-01 |
| Normal_Weight-vs-Obese |
4.215400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.387200E-01 |
| Extreme_Weight-vs-Obese |
3.113800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.740000E-01 |
| Obese-vs-Extreme_Obese |
5.175400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.937700E-02 |
| Normal-vs-Age(41-60Yrs) |
6.746400E-01 |
| Normal-vs-Age(61-80Yrs) |
2.636400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.210340E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.299170E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.862800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.000800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.051900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.262180E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.404200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.863800E-01 |
| Normal-VS-Type2 PRCC |
3.138400E-02 |
| Normal-VS-KIRP CIMP |
7.766200E-04 |
| Normal-VS-Unclassified PRCC |
8.590800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.363630E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.809500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.056200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.895220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.685400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.965800E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.555900E-03 |
| Normal-vs-N1 |
4.806300E-02 |
| Normal-vs-N2 |
1.013570E-01 |
| N0-vs-N1 |
7.555600E-01 |
| N0-vs-N2 |
9.036600E-01 |
| N1-vs-N2 |
7.848000E-01 |
|
|
